Company Data

StageZero Life Sciences Ltd

Ticker
SZLSF
Current Price
$0.0215
Market Cap
$2.7M
Price Target
Refer to Report
52wk Range
$0.0015 - $0.9999
Advanced Market Data

Overview

StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient’s current risk of having colorectal cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy